Afrezza® INHALE-1 Study in Pediatrics
Study sponsor: Mannkind Corporation
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-10-03Actual
Enrollment · participants319Actual
Source updated2025-05-06Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.